Irbesartan vs Rituximab

## Irbesartan vs Rituximab: Overview

This comparison examines the pharmacological differences between **Irbesartan** and **Rituximab**.

## Mechanism of Action

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Irbesartan — 11-15 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Irbesartan — C25H28N6O; Rituximab — N/A.

**Molecular Weight**: Irbesartan — 428.5320 g/mol; Rituximab — N/A.

**Type**: Irbesartan — Small molecule; Rituximab — Antibody.